ATYR
aTyr Pharma, Inc.
NASDAQ: ATYR · HEALTHCARE · BIOTECHNOLOGY
$0.81
+5.54% today
Updated 2026-04-30
Market cap
$76.98M
P/E ratio
—
P/S ratio
405.16x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$1 – $7
Volume
1.1M
aTyr Pharma, Inc. (ATYR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |